Investigating how glucocorticoids affect outcomes in critically ill patients
Glucocorticoids in short- and long-term critical illness outcomes
This study is looking at how a type of steroid hormone called glucocorticoids can help improve recovery for people who have been very sick, especially focusing on how it affects their mental health and memory after sepsis, so we can make this treatment work better for them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11121086 on NIH RePORTER |
What this research studies
This research focuses on understanding how glucocorticoids, a type of steroid hormone, can improve outcomes for patients suffering from critical illnesses. The study will explore the biological mechanisms behind glucocorticoid treatment, particularly its effects on mental health and memory in sepsis survivors. Researchers will also investigate how glucocorticoid signaling in the brainstem influences cardiovascular and immune responses during critical health challenges. By addressing these areas, the research aims to enhance the effectiveness of glucocorticoid therapy in critically ill patients.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients who have survived sepsis or are experiencing critical illness requiring glucocorticoid treatment.
Not a fit: Patients with non-critical illnesses or those not receiving glucocorticoid therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved survival rates and better mental health outcomes for critically ill patients.
How similar studies have performed: Previous research has shown promising results regarding the use of glucocorticoids in critical illness, indicating that this approach has potential for significant impact.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Spencer-Segal, Joanna Louise — University of Michigan at Ann Arbor
- Study coordinator: Spencer-Segal, Joanna Louise
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.